Skip to main content
Premium Trial:

Request an Annual Quote


With Operation Warp Speed, US officials hope to have a COVID-19 vaccine in place by the end of the year, but the Los Angeles Times cautions that vaccine development usually requires a dose of patience.

It notes that only seven new vaccines have been approved in the US in the past 25 years, as developers have to negotiate not only the intricacies of the immune system and the slyness of pathogens, but also the economic and regulatory realities. 

With this initiative, though, President Donald Trump has ordered academics, government officials, private companies, and the military to work together to get 300 million doses of a vaccine ready by January 2021, the LA Times reports. It notes that to do this, many steps that would typically occur sequentially will have to be done in parallel. Additionally, the effort has already awarded more than $2 billion to five companies that have vaccine candidates at different stages of development, it adds.

Vaccine experts are cautiously optimistic, according to the LA Times. "It's fine for politicians to say we're going to have a vaccine next month," the Mayo Clinic's Gregory Poland tells it. "But the literature is littered with false starts and unanticipated safety effects in vaccines."

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.